+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Direct-to-Consumer Genetic Testing Market - Global Forecast 2026-2032- Product Image
Direct-to-Consumer Genetic Testing Market - Global Forecast 2026-2032- Product Image
New

Direct-to-Consumer Genetic Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968843
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The direct-to-consumer genetic testing market is witnessing transformation as senior leaders navigate rising consumer expectations, regulatory changes, and increasing demands for innovation and privacy. Executives must make decisions with a sharp focus on sustainable growth, operational resilience, and regulatory alignment.

Market Snapshot: Direct-to-Consumer Genetic Testing Market

The direct-to-consumer genetic testing market is expanding at a robust pace, valued at USD 2.79 billion in 2025 and projected to reach USD 8.73 billion by 2032. With a CAGR of 17.70% for the period, the sector benefits from advances in sequencing technologies, heightened consumer interest in health and ancestry, and the proliferation of digital health services. Companies face intensifying competition resulting from regulatory scrutiny, evolving data privacy standards, and continuing technological improvements. Stakeholders are rapidly adjusting strategies to build resilience and capitalize on emerging opportunities as the market structure shifts.

Scope & Segmentation

This report covers the essential segments, operational context, and technology drivers of the direct-to-consumer genetic testing market. The analysis provides visibility into segment-level challenges and the strategic considerations relevant to organizations engaged in this space.

  • Ancestry Testing: Solutions leveraging autosomal, mitochondrial, and Y-chromosome analysis to address the growing demand for understanding lineage and heritage. This segment attracts varied consumer interest linked to global migration patterns and familial discovery.
  • Health Risk Testing: Tests covering both monogenic and polygenic disease susceptibility provide actionable health insights for proactive personal management, with increased relevance to chronic disease prevention and early intervention strategies.
  • Trait Testing: Offerings that include behavioral, physical, and wellness attributes (such as sleep quality, caffeine metabolism, and vitamin absorption), meeting consumer curiosity around individual characteristics.
  • Nutritional and Fitness Testing: Tools that evaluate genetic factors influencing fitness potential, performance, and nutritional needs, empowering consumers to personalize health and fitness regimens based on reliable data.
  • Pharmacogenomic Testing: Genetic screening to inform medication response, particularly in clinical areas including oncology, cardiovascular disease, and mental health, supporting precision medicine in consumer and clinical settings.
  • Paternity Testing: Applications in prenatal and postnatal contexts, requiring careful management of consent and sensitive protocols to address privacy and emotional considerations for all parties involved.
  • Regions: The Americas, Europe Middle East & Africa, and Asia-Pacific each show unique adoption patterns influenced by local regulatory requirements and consumer attitudes toward data privacy and health management.
  • Technologies: Genotyping arrays, next-generation sequencing, computational variant analysis, and data security frameworks drive value creation and end-user trust through accuracy and protection of private information.

Key Takeaways for Senior Decision-Makers

  • Integrated genomic platforms now support a continuum of consumer health, shifting from basic test results to more comprehensive, actionable health journeys and preventive care models.
  • Responses to growing regulatory oversight include investments in clinical validation protocols, clear communication of risk, and transparent consent processes, all of which strengthen long-term trust and align with evolving governance expectations.
  • Businesses benefit from tailoring their service portfolios, offering both focused products such as ancestry discovery and full-spectrum health and wellness insights, enhancing differentiation and medical integration through partnerships with clinicians.
  • Upholding rigorous standards for data governance and privacy is essential for forging strong payer relationships and securing customer loyalty amid increasing concerns over data use and security.
  • Operational robustness is achieved through diversified supplier networks, regionally adapted inventory management, and flexible procurement methods that enable organizations to anticipate and respond to risks in supply and logistics.
  • Translating technical advances into direct benefits for users requires aligning innovations with the expectations of regulators and payers, supporting broad market adoption and defensible, sustainable business models.

Tariff Impact: Supply Chain and Procurement Strategies

United States tariffs in 2025 markedly influenced the direct-to-consumer genetic testing market by increasing costs for key laboratory equipment and reagents. In response, companies expanded supplier diversification and prioritized building regional inventories to mitigate disruptions. Strategic supply chain management now centers on flexible contracting, structured risk communication with stakeholders, and resilience-focused procurement. These adaptations ensure business continuity and limit exposure to ongoing global trade uncertainties.

Methodology & Data Sources

This research leverages expert insights from laboratory directors, regulatory specialists, and commercial leaders, complemented by peer-reviewed publications, regulatory filings, and technical database cross-verification. Scenario planning and thematic assessments underpin guidance for senior leaders seeking robust, forward-facing strategies in the evolving direct-to-consumer genetic testing industry.

Why This Report Matters

  • Equips executive leaders with the knowledge to identify high-potential segments and anticipate regulatory trends, informing prudent investments in innovation and validation.
  • Provides actionable strategies for commercial teams aiming to strengthen data protection, enhance consumer trust, and secure durable market advantages under rising competition.
  • Enables operations executives to proactively manage logistics, regulatory change, and compliance uncertainty, maintaining business resilience and responding confidently to persisting industry shifts.

Conclusion

Progress across innovation, operational protocols, and consumer trust remains central to leadership in the direct-to-consumer genetic testing sector. This report delivers a roadmap for responsible growth and enduring operational stability in a dynamic market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Direct-to-Consumer Genetic Testing Market, by Ancestry Testing
8.1. Autosomal
8.2. Mitochondrial
8.3. Y-Chromosome
9. Direct-to-Consumer Genetic Testing Market, by Health Risk Testing
9.1. Monogenic Disease Risk
9.1.1. Carrier Screening
9.1.2. Single Gene Tests
9.2. Polygenic Disease Risk
9.2.1. Cardiovascular Risk
9.2.2. Oncology Risk
10. Direct-to-Consumer Genetic Testing Market, by Trait Testing
10.1. Behavioral Traits
10.1.1. Sleep Patterns
10.1.2. Stress Response
10.2. Physical Traits
10.2.1. Eye Color
10.2.2. Hair Color
10.3. Wellness Traits
10.3.1. Caffeine Metabolism
10.3.2. Vitamin Absorption
11. Direct-to-Consumer Genetic Testing Market, by Nutritional And Fitness Testing
11.1. Fitness Optimization
11.1.1. Endurance Profiling
11.1.2. Muscle Performance
11.2. Nutrient Deficiency
11.2.1. Mineral Deficiency
11.2.2. Vitamin D Deficiency
12. Direct-to-Consumer Genetic Testing Market, by Pharmacogenomic Testing
12.1. Cardiovascular Drugs
12.2. Oncology Drugs
12.3. Psychiatric Drugs
12.3.1. Antidepressants
12.3.2. Antipsychotics
13. Direct-to-Consumer Genetic Testing Market, by Paternity Testing
13.1. Postnatal
13.2. Prenatal
14. Direct-to-Consumer Genetic Testing Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Direct-to-Consumer Genetic Testing Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Direct-to-Consumer Genetic Testing Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Direct-to-Consumer Genetic Testing Market
18. China Direct-to-Consumer Genetic Testing Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. 23andMe Holding Co.
19.6. 24Genetics S.L.
19.7. Ancestry.com LLC
19.8. Color Health, Inc.
19.9. Dante Labs S.r.l.
19.10. DNAfit Ltd.
19.11. Futura Genetics d.o.o.
19.12. Gene by Gene, Ltd.
19.13. GenePlanet d.o.o.
19.14. Helix OpCo, Inc.
19.15. Invitae Corporation
19.16. Living DNA Limited
19.17. Living DNA Limited
19.18. Mapmygenome Diagnostics Pvt. Ltd.
19.19. MyHeritage Ltd.
19.20. Nebula Genomics, Inc.
19.21. Orig3n, Inc.
19.22. Prenetics Ltd.
19.23. Veritas Genetics, Inc.
19.24. Vitagene, Inc.
List of Figures
FIGURE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AUTOSOMAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AUTOSOMAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY AUTOSOMAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y-CHROMOSOME, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y-CHROMOSOME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY Y-CHROMOSOME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE GENE TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE GENE TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SINGLE GENE TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR RISK, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR RISK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR RISK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY RISK, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY RISK, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY RISK, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SLEEP PATTERNS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SLEEP PATTERNS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SLEEP PATTERNS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STRESS RESPONSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STRESS RESPONSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY STRESS RESPONSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EYE COLOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EYE COLOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY EYE COLOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HAIR COLOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HAIR COLOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HAIR COLOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CAFFEINE METABOLISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CAFFEINE METABOLISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CAFFEINE METABOLISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN ABSORPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN ABSORPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN ABSORPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ENDURANCE PROFILING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ENDURANCE PROFILING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ENDURANCE PROFILING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MUSCLE PERFORMANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MUSCLE PERFORMANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MUSCLE PERFORMANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MINERAL DEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MINERAL DEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MINERAL DEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN D DEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN D DEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY VITAMIN D DEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ONCOLOGY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIDEPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIDEPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIPSYCHOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIPSYCHOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANTIPSYCHOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POSTNATAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POSTNATAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POSTNATAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRENATAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRENATAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PRENATAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 170. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 172. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 173. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 174. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 175. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 176. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 179. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 180. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 183. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 200. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 202. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 203. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 204. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 205. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 206. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 207. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 208. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 209. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 210. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 211. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 212. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 213. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 214. AFRICA DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 233. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 234. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 235. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 236. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 237. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 238. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 239. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 240. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 241. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 242. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 243. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 244. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 245. ASEAN DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 246. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 248. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 249. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 250. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 251. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 252. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 253. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 254. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 255. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 256. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 257. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 258. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 259. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 260. GCC DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY HEALTH RISK TESTING, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY MONOGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY POLYGENIC DISEASE RISK, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY TRAIT TESTING, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY BEHAVIORAL TRAITS, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHYSICAL TRAITS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY WELLNESS TRAITS, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRITIONAL AND FITNESS TESTING, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY FITNESS OPTIMIZATION, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY NUTRIENT DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMIC TESTING, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PSYCHIATRIC DRUGS, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY PATERNITY TESTING, 2018-2032 (USD MILLION)
TABLE 276. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 277. BRICS DIRECT-TO-CONSUMER GENETIC TESTING MARKET SIZE, BY ANCESTRY TESTING, 201

Companies Mentioned

The key companies profiled in this Direct-to-Consumer Genetic Testing market report include:
  • 23andMe Holding Co.
  • 24Genetics S.L.
  • Ancestry.com LLC
  • Color Health, Inc.
  • Dante Labs S.r.l.
  • DNAfit Ltd.
  • Futura Genetics d.o.o.
  • Gene by Gene, Ltd.
  • GenePlanet d.o.o.
  • Helix OpCo, Inc.
  • Invitae Corporation
  • Living DNA Limited
  • Living DNA Limited
  • Mapmygenome Diagnostics Pvt. Ltd.
  • MyHeritage Ltd.
  • Nebula Genomics, Inc.
  • Orig3n, Inc.
  • Prenetics Ltd.
  • Veritas Genetics, Inc.
  • Vitagene, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.25 Billion
Forecasted Market Value ( USD ) by 2032 $ 8.73 Billion
Compound Annual Growth Rate17.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Direct-to-Consumer (DTC) Genetic Testing Market - Test Types, Technologies and Distribution Channels - Product Image

Direct-to-Consumer (DTC) Genetic Testing Market - Test Types, Technologies and Distribution Channels

  • Report
  • 262 Pages
  • Global
From
Direct-to-Consumer (DTC) Genetic Testing Market Report 2025 - Product Image

Direct-to-Consumer (DTC) Genetic Testing Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Direct-to-Consumer Genetic Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Direct-to-Consumer Genetic Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 125 Pages
  • Global
From
Predictive Genetic Testing and Consumer Genomics Market Report 2025 - Product Image

Predictive Genetic Testing and Consumer Genomics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Direct-to-consumer DNA Genetic Testing Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Direct-to-consumer DNA Genetic Testing Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 89 Pages
  • Global
From

About the Direct to Consumer Genetic Testing Market

Direct to Consumer Genetic Testing (DTCGT) is a type of genetic testing that allows individuals to access their genetic information without the need for a doctor or other healthcare provider. DTCGT companies provide genetic testing services directly to consumers, typically through a simple saliva sample. The results of the test can provide insight into an individual's ancestry, health risks, and other genetic traits. The DTCGT market has grown rapidly in recent years, driven by advances in genomics technology and the increasing availability of affordable testing services. Consumers are increasingly turning to DTCGT to gain access to their genetic information and to learn more about their health and ancestry. Some of the leading companies in the DTCGT market include 23andMe, AncestryDNA, Helix, and MyHeritage. These companies offer a range of services, from ancestry testing to health risk assessments. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.